New Delhi: Drug major Sanofi Healthcare India has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct the clinical ...

Potent topical steroids outperform mild ones in treating moderate atopic dermatitis in children, improving symptom control and quality of life.

Ruxolitinib cream 1.5% was safe and effective for the treatment of children and adolescents with a 35% or greater body surface areas affected by atopic dermatitis, according to a study.Ruxolitinib ...

Newly published study in a leading peer-reviewed, international journal, Veterinary Dermatology, compares clinical outcomes ...

Astria Therapeutics' focus on leveraging its half-life extension technology to create long-acting mAbs targeting derisked targets in established markets has positioned the company favorably in the ...

Jonathan Wolleben, an analyst from JMP Securities, has initiated a new Buy rating on Astria Therapeutics (ATXS).Invest with Confidence: Follow ...

Researchers studied genetically modified mice that lack NP2 itch-sensing neurons, to investigate the connection between itch, scratch, and inflammation.

Atopic dermatitis is one of the most common types of eczema. Signs may include inflamed skin, rash, itchiness and excessive dryness. It may also include bumps and swollen skin that may ooze. It ...

Data from a retrospective multicenter study, along with a review of previous trials, supported the real-world utility of ...

Self-reported manifestations of topical steroid withdrawal in atopic dermatitis include erythema, desquamation, dryness, and oozing.

AD, The most common inflammatory skin disorder worldwide, is a highly heterogeneous condition with current treatments that do ...

Apogee Therapeutics develops therapies for inflammatory autoimmune diseases. Find out why I'm bearish on APGE stock.